Trade Nurix Therapeutics, Inc. - NRIX CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.18 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023401% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.001179% | ||||||||
| Overnight fee time | 22:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 50.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 19.49 |
| Open | 19.45 |
| 1-Year Change | -0.21% |
| Day's Range | 19.03 - 19.49 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Dec 24, 2024 | 19.49 | -0.23 | -1.17% | 19.72 | 19.72 | 19.01 |
| Dec 23, 2024 | 19.91 | 0.23 | 1.17% | 19.68 | 20.08 | 19.23 |
| Dec 20, 2024 | 19.77 | -0.05 | -0.25% | 19.82 | 20.54 | 19.39 |
| Dec 19, 2024 | 19.97 | -0.15 | -0.75% | 20.12 | 20.35 | 19.29 |
| Dec 18, 2024 | 20.19 | -0.89 | -4.22% | 21.08 | 21.57 | 19.50 |
| Dec 17, 2024 | 21.10 | 0.80 | 3.94% | 20.30 | 21.24 | 20.21 |
| Dec 16, 2024 | 20.73 | 0.70 | 3.49% | 20.03 | 21.24 | 19.95 |
| Dec 13, 2024 | 20.22 | -0.08 | -0.39% | 20.30 | 20.61 | 19.83 |
| Dec 12, 2024 | 20.51 | -0.52 | -2.47% | 21.03 | 21.53 | 20.15 |
| Dec 11, 2024 | 21.22 | -1.24 | -5.52% | 22.46 | 22.77 | 20.91 |
| Dec 10, 2024 | 22.01 | 1.06 | 5.06% | 20.95 | 22.75 | 20.95 |
| Dec 9, 2024 | 20.58 | -0.48 | -2.28% | 21.06 | 21.89 | 20.20 |
| Dec 6, 2024 | 21.31 | 1.16 | 5.76% | 20.15 | 21.97 | 20.15 |
| Dec 5, 2024 | 20.00 | -0.66 | -3.19% | 20.66 | 21.24 | 19.95 |
| Dec 4, 2024 | 20.76 | 0.15 | 0.73% | 20.61 | 21.21 | 20.59 |
| Dec 3, 2024 | 20.81 | -0.19 | -0.90% | 21.00 | 21.42 | 20.54 |
| Dec 2, 2024 | 21.44 | -0.49 | -2.23% | 21.93 | 22.05 | 21.31 |
| Nov 29, 2024 | 21.95 | 0.76 | 3.59% | 21.19 | 22.15 | 21.02 |
| Nov 27, 2024 | 21.15 | -0.52 | -2.40% | 21.67 | 21.97 | 21.14 |
| Nov 26, 2024 | 21.71 | 0.15 | 0.70% | 21.56 | 22.01 | 21.06 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 20
- 100
- 500
- 1000
- 10000
Nurix Therapeutics, Inc.
Nurix Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapies for the treatment of cancer and immune disorders. The company develops NX-2127, an orally available Bruton''s tyrosine kinase (BTK) degrader with immunomodulatory drug (IMiD) activity for the treatment of relapsed or refractory B-cell malignancies; NX-5948, an orally bioavailable BTK degrader without IMiD activity for the treatment of relapsed or refractory B-cell malignancies; and NX-1607, an orally available Casitas B-lineage lymphoma proto-oncogene-B (CBL-B) inhibitor for immuno-oncology indications. It also develops NX-0255, a CBL-B inhibitor for ex vivo use to enhance adoptive T-cell therapy; DeTIL-0255 for tumor infiltrating lymphocytes therapy; KINASE-CTM3 to treat T cell malignancies and autoimmune diseases; and LIGASE-INH2 for immuno-oncology. In addition, the company develops programs, such as COVID-CTM1, COVID-CTM2, and COVID-CTM3 that are designed for protein degradation to SARs CoV2 targets. Nurix Therapeutics, Inc. has a strategic collaboration agreement with Gilead Sciences, Inc. for cancer and other challenging diseases patients; and Sanofi S.A. The company was formerly known as Nurix Inc. and changed its name to Nurix Therapeutics, Inc. in October 2018. Nurix Therapeutics, Inc. was incorporated in 2009 and is headquartered in San Francisco, California.News
Pi Network coin price prediction: Third party price target
Discover the Pi Network coin price predictions for 2025 onward, with analyst outlooks, price targets and CFDs trading strategies on Capital.com
13:51, 13 December 2024
Euro forecast: third party data roundup
In 2024, the euro’s outlook appeared more stable. Read on for our 2025 and beyond insights.
22:39, 12 December 2024
Projected US interest rates in 5 years: Third party round up
As the US central bank starts its cutting cycle, what are the projected interest rates in 5 years?
14:28, 12 December 2024
Projected UK interest rates in 5 years
Bank of England (BoE) cut rates for the first time in August 2024, with further easing expected in the coming months. But how low are rates likely to go?
11:20, 12 December 2024
Dogecoin (DOGE) price prediction 2025-2030: Could Dogecoin reach $1? - Third party price target
We look at the meme coin’s price performance and the latest DOGE price predictions
08:37, 12 December 2024
Gold price predictions for the next five years: Third party data round up
Explore the future of gold prices and whether the yellow metal will continue its upward trend in the coming years.
09:13, 6 December 2024
Bitcoin price predictions 2025–2050: third-party price target
We examine bitcoin price predictions for 2025 and beyond, with insights from third-party analysts and market experts.
12:47, 5 December 2024People also watch
Still looking for a broker you can trust?
Join the 660,000+ traders worldwide that chose to trade with Capital.com